{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:20:34Z","timestamp":1783059634171,"version":"3.54.6"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","award":["FRN 183092"],"award-info":[{"award-number":["FRN 183092"]}],"id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","award":["PPE 190332"],"award-info":[{"award-number":["PPE 190332"]}],"id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008097","name":"Department of Family and Community Medicine, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cct.2026.108303","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:43:25Z","timestamp":1776113005000},"page":"108303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lessons learned and recommendations from the Canadian adaptive platform trial of treatments for COVID in community settings (CanTreatCOVID)"],"prefix":"10.1016","volume":"165","author":[{"given":"Banafshe","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Condon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno R.","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Greiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"McBrien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cct.2026.108303_bb0005","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1016\/S2589-7500(20)30086-8","article-title":"A real-time dashboard of clinical trials for COVID-19","volume":"2","author":"Thorlund","year":"2020","journal-title":"Lancet Digit Health"},{"issue":"1","key":"10.1016\/j.cct.2026.108303_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.amjmed.2020.07.003","article-title":"Pathophysiological basis and rationale for early outpatient treatment of SARS-CoV-2 (COVID-19) infection","volume":"134","author":"McCullough","year":"2021","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.cct.2026.108303_bb0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/19466315.2020.1790415","article-title":"Efficient adaptive designs for clinical trials of interventions for COVID-19","volume":"12","author":"Stallard","year":"2020","journal-title":"Stat Biopharm Res"},{"issue":"1","key":"10.1016\/j.cct.2026.108303_bb0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra1510062","article-title":"Master protocols to study multiple therapies, multiple diseases, or both","volume":"377","author":"Woodcock","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.cct.2026.108303_bb0025","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1001\/jama.2015.2316","article-title":"The platform trial","volume":"313","author":"Berry","year":"2015","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.cct.2026.108303_bb0030","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41573-019-0034-3","article-title":"Adaptive platform trials: definition, design, conduct and reporting considerations","volume":"18","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.cct.2026.108303_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.2021.22507","article-title":"How to use and interpret the results of a platform trial","volume":"327","author":"Park","year":"2022","journal-title":"JAMA"},{"issue":"10259","key":"10.1016\/j.cct.2026.108303_bb0040","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)32013-4","article-title":"Lopinavir\u2013ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"396","author":"Horby","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cct.2026.108303_bb0045","article-title":"ACTIV trials: cross-trial lessons learned for master protocol implementation","volume":"8","author":"Keshtkar-Jahromi","year":"2024","journal-title":"J Clin Transl Sci"},{"issue":"Supplement_2","key":"10.1016\/j.cct.2026.108303_bb0050","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/infdis\/jiad246","article-title":"ACTIV-2: a platform trial for the evaluation of novel therapeutics for the treatment of early COVID-19 in outpatients","volume":"228","author":"Currier","year":"2023","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.cct.2026.108303_bb0055","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design","volume":"17","author":"Angus","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"10279","key":"10.1016\/j.cct.2026.108303_bb0060","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(21)00461-X","article-title":"Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial","volume":"397","author":"Butler","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2026.108303_bb0065","doi-asserted-by":"crossref","DOI":"10.12688\/gatesopenres.13304.2","article-title":"A multi-center, adaptive, randomized, platform trial to evaluate the effect of repurposed medicines in outpatients with early coronavirus disease 2019 (COVID-19) and high-risk for complications: the TOGETHER master trial protocol","volume":"5","author":"Reis","year":"2021","journal-title":"Gates Open Res."},{"key":"10.1016\/j.cct.2026.108303_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106625","article-title":"Implementation of platform trials in the COVID-19 pandemic: a rapid review","volume":"112","author":"Vanderbeek","year":"2022","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.cct.2026.108303_bb0075","series-title":"Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): Protocol for a Randomized Controlled Adaptive Platform Trial of Treatments for Acute SARS-CoV-2 Infection in Community Settings","author":"Hosseini","year":"2024"},{"issue":"2","key":"10.1016\/j.cct.2026.108303_bb0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4269\/ajtmh.21-1202","article-title":"Resilient clinical trial infrastructure in response to the COVID-19 pandemic: lessons learned from the TOGETHER randomized platform clinical trial","volume":"106","author":"Forrest","year":"2022","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.cct.2026.108303_bb0085","author":"Muskoka"},{"key":"10.1016\/j.cct.2026.108303_bb0090","author":"Government of Canada: Panel on Research Ethics"},{"key":"10.1016\/j.cct.2026.108303_bb0095","author":"CanReview"},{"issue":"10373","key":"10.1016\/j.cct.2026.108303_bb0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(22)02597-1","article-title":"Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial","volume":"401","author":"Butler","year":"2023","journal-title":"Lancet"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714426000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:42:05Z","timestamp":1783057325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714426000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":20,"alternative-id":["S1551714426000893"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2026.108303","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons learned and recommendations from the Canadian adaptive platform trial of treatments for COVID in community settings (CanTreatCOVID)","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2026.108303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108303"}}